权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Evaluating the feasibility of a primary care-based treatment for restrictive eating disorders in children and adolescents

评估针对儿童和青少年限制性饮食失调的初级保健治疗的可行性

基本信息

批准号：
10569776
负责人：
Jocelyn Rebecca Lebow
金额：
$ 23.85万
依托单位：
MAYO CLINIC ROCHESTER
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-02-15 至 2026-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10569776
关键词：
Address Adolescent Affect Age Ambulatory Care American Anorexia Belief Body Weight Caregiver support Caregivers Caring Case Series Certification Cessation of life Characteristics Child Chronic Clinic Communities Data Democracy Disease remission Distance Learning Early Intervention Eating Disorders Educational process of instructing Effectiveness Evaluation Evidence based treatment Family Goals Health Services Accessibility Healthcare Systems Intervention Interview Life Link Manuals Measures Medical Mental disorders Methodology Methods Nature Outcome Parents Patient Care Patient-Focused Outcomes Patients Perception Pilot Projects Play Positioning Attribute Pragmatic clinical trial Preparation Primary Care Process Protocols documentation Provider Questionnaires Randomized Randomized, Controlled Trials Recording of previous events Recovery Reporting Role Sampling Self Efficacy Severities Suicide Survey Methodology Symptoms Testing Training United States acceptability and feasibility access disparities arm behavior change comparison intervention design effective therapy eligible participant empowerment evidence base experience family burden feasibility testing illness length illness perceptions improved improved outcome intervention delivery meetings mortality novel operation participant enrollment patient responsibilities pediatric patients pilot trial pragmatic trial primary care provider primary care setting recruit reduce symptoms restrictive eating retention rate rural setting tool tool development treatment strategy treatment trial trend weight restoration

项目摘要

ABSTRACT In the United States, half a million adolescents suffer from an eating disorder. With only 66 certified providers nationally, Family-Based Treatment (FBT), a first-line evidence-based treatment for adolescent eating disorders, is not readily available to most families. This provider shortage leaves most young patients without care and undoubtedly contributes to the chronicity and lethality of these conditions. Patients with eating disorders generally make their first contact with the healthcare system in primary care. As such, equipping primary care providers (PCPs) with effective means to treat these patients has potential to democratize care, improve rates of early intervention, and enhance patient outcomes. Family-Based Treatment for Primary Care (FBT-PC) is a novel intervention for delivery by a PCP in primary care that uses FBT strategies. Data support proof-of-concept for this adaptation. We have several study aims. (1) We will finalize the FB-PC intervention through an open case series. (2) We will establish the feasibility and acceptability of FBT-PC for caregivers, patients, and PCPs in a pilot randomized controlled trial. Finally, (3) we will test preliminary target engagement of FBT-PC and determine whether it is associated with improved caregiver self-efficacy and, through this mechanism, symptom remission. Remission will be defined as weight restoration to 95% of expected body weight and a score within 1 SD of community norms on the Eating Disorder Examination-Questionnaire. We also propose (4) an exploratory aim to evaluate baseline characteristics of our sample to determine for whom the FBT-PC intervention is most beneficial. To accomplish all aims we will complete an open case series (n = 6), followed by a pilot trial in which we will randomly assign 40 patients (ages 7-18 years) with restrictive eating disorders and their caregiver(s) to FBT-PC or a control condition of standard FBT. Families will attend up to 18 sessions over 6 months. Goals from the open case series (Aim 1) will include the development of tools for FBT-PC training and implementation, including treatment and training protocols and fidelity measures. Feasibility (Aim 2) will be assessed through an evaluation of recruitment and retention. Acceptability (Aim 2) will be evaluated using mixed methods surveys and interviews of caregivers, patients and PCPs on the topics of tolerability, fit, and burden. We will also assess the degree to which FBT-PC engages our proposed mechanism of change, caregiver self-efficacy, to facilitate symptom remission (Aim 3). Effect sizes will be calculated for FBT-PC with a goal of ≥ 0.5, comparable with those found in FBT trials. Finally, baseline sample characteristics (Exploratory Aim) will be assessed including caregiver perceptions about their child’s illness, referral method, length of illness, and symptom severity. Once we have established feasibility, acceptability, and target engagement of the FBT-PC intervention, we intend to use these findings in support of a large pragmatic clinical trial to evaluate the noninferiority of effectiveness of FBT-PC versus standard FBT.

摘要